Xolair Genentech, Inc. - Treatment for Asthma

Xolair is a recombinant DNA-derived humanized IgG1 monoclonal antibody that selectively binds to human immunoglobulin E (IgE). Xolair is used to treat moderate to severe persistent asthma.

Posted: June 2003

Related Articles:

View comments

Hide
(web2)